Trial Profile
The efficacy and safety of intra-articular injections with the TNF [tumour necrosis factor]-a antagonist infliximab in patients with chronic or recurrent arthritis of the knee.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Jan 2021
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Methylprednisolone
- Indications Osteoarthritis
- Focus Therapeutic Use
- 23 Sep 2009 Additional lead trial centre identified, additional trial location (Netherlands) identified as reported by Netherlands Trial Register record.
- 22 Sep 2009 New source identified and integrated (Netherlands Trial Register).
- 15 Jul 2009 Results were published in Arthritis and Rheumatism.